Early thrombolytic therapy is beneficial to cardiac protection, cardiac function and ventricular remodeling.

After 4 weeks, cardiac function, bore in left ventricular end-systolic stage and bore in left ventricular end-diastolic stage were measured with heart ultrasound to assess the ventricular remodeling.

Many studies have shown that inhibiting or attenuating cardiomyocyte apoptosis can prevent ventricular remodeling after myocardial infarction and improve cardiac function.